Campus des Technologies de la Santé/CTS Healthcare
VC Fund
Quebec, Canada
Campus des Technologies de la Santé/CTS Healthcare is a VC fund in Quebec focused on Health Care and Medical Device. The Campus des Technologies de la Santé/CTS Healthcare provides services to promote the growth and development of companies in the medical sector. Their mission is to ensure the development and sustainability of health sector companies and to contribute to their national and international influence.To achieve this goal, services are offeredto both Quebec and international companies. These services are based on the following philosophies:•The importance of a strong network; •Access to experienced mentors; •Business intelligence and prompt action
- Total investments:
- 14
- Last investment:
- Lead investor:
- 7%
Last updated:
For AI agents: llms.txt
Industries Campus des Technologies de la Santé/CTS Healthcare invests in
Stages Campus des Technologies de la Santé/CTS Healthcare invests in
Countries Campus des Technologies de la Santé/CTS Healthcare invests in
Investment Focus
Industry
- Health Care 10 (71%)
- Medical Device 5 (36%)
- Artificial Intelligence 4 (29%)
- Software 3 (21%)
- Medical 2 (14%)
Stage
- Seed 6 (43%)
- Non-equity Assistance 5 (36%)
- Pre-Seed 3 (21%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
We streamline interactions with healthcare professionals for insurance companies and pharmaceutical companies. We fast forward the management cycle of their APS (Attending Physician Statement) forms. On Redeo, healthcare providers can now read, duplicate past forms, complete, digitally sign, and most importantly securely transmit forms such asdisability forms or pre-authorization forms for biosimilars or chemotherapy. Our platform API securely transmits the forms inherent granular data directly to the case management software of insurance companies and patient support programs (PSP) of pharmaceutical companies thus fast forwarding key decisions in patient care and ultimately fast forwarding patients return to work. | Seed / Jan 01, 2024 | |
|
|
Founded in 2015, NeuroServo has developed a miniaturized portable electroencephalogram (EEG) for the early diagnosis of postoperative delirium, a condition that’s dangerous for patients (permanent cognitive loss) and very costly for the healthcare system. Integrated into a cap, the device can also be used to assess children and adolescentssuffering from attention deficit disorder (ADHD) or autism. | Non-equity Assistance / Apr 19, 2023 | |
|
|
Haply is a robotics company that provides haptic devices, prototyping, firmware, and virtual learning assistance. | Non-equity Assistance / Apr 19, 2023 | |
|
|
Ora Medical's rehabilitation technology helps children with mobility challenges. The Levity, our first device, is a smart pediatric gait trainer that supports a child with an innovative partial weight-bearing mechanism. This allows the child to interact with the world using their arms, unlocking tons of possibilities for enhanced independenceand freedom. The real-time data collected helps parents and clinicians track each child's journey. | Non-equity Assistance / Apr 19, 2023 | |
|
|
Statera Medical develops next-generation shoulder prosthesis to increase patients' quality of life, without compromises. | Non-equity Assistance / Apr 19, 2023 | |
|
|
Paperplane Therapeutics is a software company that designs therapeutic virtual reality video games for children suffering from anxiety. | Non-equity Assistance / Apr 19, 2023 | |
|
|
AssistIQ delivers supply intelligence to health systems, reducing waste and carbon footprint without impacting patient quality with no added work. | $1.8M / Seed / Feb 28, 2023 | |
|
|
We provide healthcare organizations with an ecosystem to simplify access to curated health software for their patients.Our vision is to become the global reference for data-driven decisions for the distribution and reimbursement of health software. We power health apps review processes, clinical decision support for healthcare providers toselect and prescribe health apps to patients, as well as patient engagement platforms to derisk and simplify health app access. | $1.7M / Pre-Seed / Nov 11, 2022 | |
|
|
Our app, Kairos - Heroes of Time, provides parental guidance and behavioral therapy for children with neurodeveloppemental disorders using avatars and gamification while monitoring medication information into shareable dashboards. We integrate AI to help professionnals identify treatment plans that best suits a child's profile. | Seed / Oct 18, 2022 | |
|
|
Zilia has developed a non-invasive platform technology that uses imaging, spectrometry and artificial intelligence to quantitatively measure different biomarkers in the human eye. Zilia’s initial product, Zilia Ocular, is the first retinal camera to quantify oxygen saturation, a crucial biomarker in ocular diseases such as glaucoma, DR and AMD.Zilia aims to revolutionize the prevention, diagnosis and management of these diseases by generating actionable data about the eye’s metabolic activity. | $3.2M / Seed / Aug 11, 2021 | |
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Campus des Technologies de la Santé/CTS Healthcare invest in?
Campus des Technologies de la Santé/CTS Healthcare invests primarily in Health Care, Medical Device and Artificial Intelligence startups, most often at Seed and Non-equity Assistance stage. Most of the 14 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Campus des Technologies de la Santé/CTS Healthcare last invest?
The most recent investment recorded for Campus des Technologies de la Santé/CTS Healthcare closed in Jan 2024. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!